ASH 2020: Dr. Christopher Pleyer Discusses the Effect of Bruton Tyrosine Kinase Inhibitors on the Efficacy of Adjuvanted Recombinant Hepatitis B and Zoster Vaccines in Patients with Chronic Lymphocytic Leukemia (CLL)

You are here: